Zobrazeno 1 - 10
of 21
pro vyhledávání: '"Mona, Malakouti"'
Publikováno v:
Dermatology Online Journal. 26
Mastocytosis is a rare condition in which mast cells accumulate throughout various organs of the body-the most common subtype being confined to the skin. We present an unusual case of cutaneous mastocytosis localized to the unilateral breast of a you
Autor:
Margit L. W. Juhász, Nanette B. Silverberg, Mona Malakouti, Sharon E. Jacob, Annelise Rasmussen, Rosemarie A. Curley
Publikováno v:
Journal of the Dermatology Nurses' Association. 9:233-240
Autor:
Kristina Lee, Mona Malakouti, Ethan Levin, Gabrielle Brown, Melissa J. Danesh, Argentina Leon, John Koo, Tian Hao Zhu, Michael Abrouk, Catherine M. Nguyen, Kourosh Beroukhim, Benjamin Farahnik, Eva Wang
Publikováno v:
Journal of Psoriasis and Psoriatic Arthritis. 1:26-30
Background Psoriasis patients experience a significant decrease in quality of life (QoL). Objectives This study was conducted to prospectively measure changes in QoL of patients with moderate-to-severe psoriasis who are treated with ustekinumab. We p
Autor:
Jashin J. Wu, Wilson Liao, Satish K. Pillai, Sarah T. Arron, Mona Malakouti, Mohamed Abdel-Mohsen, Gabrielle Brown, Rui André Saraiva Raposo, Kaitlyn S. Leadabrand, Peter J. Kuebler, Rashmi Gupta, Maya Debbaneh, Michelle Dimon, W. Jiang, Vanessa A. York, Douglas F. Nixon
Publikováno v:
Journal of the European Academy of Dermatology and Venereology : JEADV, vol 29, iss 10
BackgroundPsoriasis patients have relatively infrequent cutaneous viral infections compared to atopic dermatitis patients. Increased expression of four antiviral proteins (MX1, BST2, ISG15 and OAS2) has been reported in psoriatic skin and genetic stu
Publikováno v:
Psoriasis Forum. :132-149
Background Some psoriasis patients respond inadequately to monotherapy and require combination therapy. Combining a biologic and nonbiologic agent may provide improvement. Objective To review the efficacy and safety of combination treatment with biol
Publikováno v:
Journal of Dermatological Treatment. 26:32-36
Background: Studies investigating the molecular basis of psoriasis have established the central roles of TNFα, interleukin (IL)-12, IL-22 and IL-23 and there is increasing evidence that IL-17 plays a critical role in the complex pathophysiology. Pre
Publikováno v:
Journal of the Dermatology Nurses' Association. 10:49-50
Publikováno v:
Journal of Dermatological Treatment. 25:78-82
Over the past 15 years, biologic medications have greatly advanced psoriasis therapy. However, these medications may lose their efficacy after long-term use, a concept known as biologic fatigue. We sought to review the available data on biologic fati
Publikováno v:
Clinical, Cosmetic and Investigational Dermatology
Psoriasis is a chronic inflammatory skin disease that has a negative impact on psychosocial well-being and cardiometabolic health. Treatment options for moderate-to-severe psoriasis have expanded with the development of interleukin-17 (IL-17) inhibit